Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Other Non Operating Income: 2015-2024

Historic Other Non Operating Income for Adma Biologics (ADMA) over the last 9 years, with Dec 2024 value amounting to $4.3 million.

  • Adma Biologics' Other Non Operating Income fell 3787.50% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 103.86%. This contributed to the annual value of $4.3 million for FY2024, which is 116.58% up from last year.
  • Per Adma Biologics' latest filing, its Other Non Operating Income stood at $4.3 million for FY2024, which was up 116.58% from -$26.2 million recorded in FY2023.
  • Over the past 5 years, Adma Biologics' Other Non Operating Income peaked at $4.3 million during FY2024, and registered a low of -$26.2 million during FY2023.
  • In the last 3 years, Adma Biologics' Other Non Operating Income had a median value of -$6.7 million in 2022 and averaged -$9.5 million.
  • In the last 5 years, Adma Biologics' Other Non Operating Income slumped by 2,546.83% in 2022 and then skyrocketed by 116.58% in 2024.
  • Adma Biologics' Other Non Operating Income (Yearly) stood at $991,797 in 2020, then plummeted by 125.41% to -$252,000 in 2021, then tumbled by 2,546.83% to -$6.7 million in 2022, then crashed by 292.41% to -$26.2 million in 2023, then soared by 116.58% to $4.3 million in 2024.